A cross-sectional study to study the role of Fine Needle Aspiration Cytology in Lymphadenitis: a study from tertiary care Hospital
Keywords:
lymphadenopathy, cervical, biopsy, fine needle aspiration cytologyAbstract
Background: In patients with lymphadenopathy, the use of fine-needle aspiration cytology (FNAC) for early diagnosis and treatment is recommended due to the ease with which enlarged lymph nodes can be aspirated. The method's simplicity and lack of complexity make it a good choice. Reactive lymphadenitis, inflammation, granulomatous illnesses, and neoplastic diseases can all be diagnosed with a high degree of accuracy using this test.Aims and Objectives: This research aims to examine the FNAC results in lymphadenitis, which are frequently encountered by this population.Materials and Methods: A hundred patients were studied at the Department of Pathology, name of study place from May 1st, 2021 to August end 2021. All slides and reports were collected and reported. Age, sex, lymphadenopathy sites, and cytological analysis findings were recorded. Results: Patients with lymphadenopathy belong to 31-40 years (56%) followed by 21-30 years (26%). With a mean age of 34.56±8.12 years, females (73%) compared to males (27%). The most common site of lymphadenopathy was cervical (69%), followed by axillary (21%), inguinal (8%), and Generalized (2%). Cytological analysis revealed that the majority of the patients were diagnosed with tuberculous lymphadenitis (47%), followed by Chronic reactive hyperplasia (24%), Acute lymphadenitis (16%), and metastatic (12%).Conclusion: Fine needle aspiration is an essential modality for the initial diagnosis and management of patients with lymphadenopathy.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Aparajita Tomar, Parul Nema, Hemlata Bamoriya, Ram Pratap Singh Chouhan

This work is licensed under a Creative Commons Attribution 4.0 International License.